Survey study on volunteers participating in clinical phase trials of the national vaccine developed against COVID-19

Authors : Zafer Sezer, Ahmet İnal, Seda Caymaz Yılmaz

Pages : 765-769

Doi:10.32322/jhsm.1733877

View : 41 | Download : 76

Publication Date : 2025-09-16

Article Type : Research Paper

Abstract :Aims: This study aimed to evaluate the sociodemographic characteristics, motivations for participation, and experiences of volunteers who took part in the phase 1 and phase 2 clinical trials of Turkovac, the first national COVID-19 vaccine developed in Turkiye. Methods: A total of 230 volunteers participated in the study. Data on their demographics and perspectives on clinical research were collected using a structured questionnaire. Results: The majority of the volunteers were male (76.1%) and residing in urban areas (87.8%). Of all participants, 91.7% were involved in the phase 2 trial and 8.3% in the phase 1 trial. Most volunteers reported that their motivation for participation was based on trust in the national vaccine. Furthermore, a significant part of the participants evaluated their clinical trial experience positively and expressed willingness to participate in future studies. Conclusion: The findings of this study may provide valuable insights for the planning of future clinical trials and the development of effective strategies to increase volunteer participation.
Keywords : Anket, COVID-19, Gönüllü, Klinik araştırmalar, Turkovac, Yerli aşı

ORIGINAL ARTICLE URL